Top

Published in:

01-01-2020 | Care | Concise Research Report

Reducing Psychotropic Use in Older Non-demented Spanish Care Home Residents: a Before-After Comparison of Three Methods

Authors: Curtis L. Petersen, MPH, David Curto, MD, MBA, Manish K. Mishra, MD, MPH, Pedro Cano, MD, William B. Weeks, MD, PhD, MBA

Published in: Journal of General Internal Medicine | Issue 1/2020

Excerpt

Recognizing that Spain has the highest rate of antipsychotic prescribing in Western Europe,¹ the Spanish Geriatrics and Gerontology Society has encouraged reducing psychotropic medication use in long-term settings.² In a quality improvement effort designed to do that, we found that administration of any of 3 interventions—application of STOPP/START criteria, medication-focused team rounds (TR), or a decision aid (DA)—effectively reduced psychotropic use among older Spanish nursing home residents with dementia, though STOPP/START criteria application was most effective.³ …

Janus SIM, van Manen JG, Ijzerman MJ, Zuidema SU. Psychotropic drug prescriptions in Western European nursing homes. Int Psychogeriatr. 2016;28(11):1775-90.CrossRef

Ramos Cordero P, Lopez Trigo JA, Maillo Pedraz H, Paz Rubio JM. [Physical and pharmacological restraints in geriatric and gerontology services and centers]. Revista espanola de geriatria y gerontologia. 2015;50(1):35-8. Epub 2014/12/03. doi: https://doi.org/10.1016/j.regg.2014.09.006.CrossRefPubMed

Weeks WB, Mishra MK, Curto D, Petersen CL, Cano P, Hswen Y, Serra SV, Elwyn G, Godfrey MM, Soro PS, Tomás JF. Comparing three methods for reducing psychotropic use in older demented spanish care home residents. J Am Geriatr Soc 2019;67:1444–53. https://doi.org/10.1111/jgs.15855.CrossRef

Wills P, Claesson CB, Fratiglioni L, Fastbom J, Thorslund M, Winblad B. Drug use by demented and non-demented elderly people. Age and ageing. 1997;26(5):383-91. Epub 1997/11/14.CrossRef

"They want docile." How nursing homes in the United States overmedicate people with dementia. https://www.hrw.org/report/2018/02/05/they-want-docile/how-nursing-homes-united-states-overmedicate-people-dementia. United States of America: Human Rights Watch, 2018.

Title: Reducing Psychotropic Use in Older Non-demented Spanish Care Home Residents: a Before-After Comparison of Three Methods
Authors: Curtis L. Petersen, MPH
David Curto, MD, MBA
Manish K. Mishra, MD, MPH
Pedro Cano, MD
William B. Weeks, MD, PhD, MBA
Publication date: 01-01-2020
Publisher: Springer US
Keywords: Care
Dementia
Dementia
Published in: Journal of General Internal Medicine / Issue 1/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05517-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Reducing Psychotropic Use in Older Non-demented Spanish Care Home Residents: a Before-After Comparison of Three Methods

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2020

Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study

Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study

Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System

Low-Value Care and Clinician Engagement in a Large Medicare Shared Savings Program ACO: a Survey of Frontline Clinicians

How Clinicians Discuss Medications During Primary Care Encounters Among Older Adults with Cognitive Impairment

Results and Lessons of a Pilot Study of Cascade Screening for Familial Hypercholesterolemia in US Primary Care Practices

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page